Carlos Cordon-Cardo

Carlos Cordon-Cardo

Department of Pathology, Icahn School of Medicine at Mount Sinai

Affiliated withIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai

Research Area

MedicineCancer Research

Biography

Carlos Cordon-Cardo has not added Biography.
If you are Carlos Cordon-Cardo and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 4
Year
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Publication title
2014
2015
2017
2019

Other Publications

Article
Year
Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Science (New York, N.Y.)| PubMed ID: 12750523

2003
Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 12777996

2003
2003
Oncogenes in melanoma.

Oncogene| PubMed ID: 12789285

2003
2003
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 12855638

2003
Gene discovery in bladder cancer progression using cDNA microarrays.

The American journal of pathology| PubMed ID: 12875971

2003
2003
2003
Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc| PubMed ID: 12920217

2003
2003
2003
p73alpha regulation by Chk1 in response to DNA damage.

Molecular and cellular biology| PubMed ID: 14585975

2003
2004
2003
2003
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 14654547

2003
2003
MDM2 and prognosis.

Molecular cancer research : MCR| PubMed ID: 14757840

2004
Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

Journal of the National Cancer Institute| PubMed ID: 14970276

2004
2004
p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 14981108

2004
2004
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology| PubMed ID: 15006913

2004
Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15014038

2004
2004
2004
2004
High-resolution characterization of the pancreatic adenocarcinoma genome.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 15199222

2004
2004
Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc| PubMed ID: 15257316

2004
2004
2004
2004
2004
2004
Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression.

Diagnostic molecular pathology : the American journal of surgical pathology, part B| PubMed ID: 15538112

2004
2004
Racial disparity of epidermal growth factor receptor expression in prostate cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 15570072

2004
Role of Dok-1 and Dok-2 in leukemia suppression.

The Journal of experimental medicine| PubMed ID: 15611295

2004
2004
Molecular profiling of tumor progression in head and neck cancer.

Archives of otolaryngology--head & neck surgery| PubMed ID: 15655179

2005
2005
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 15722787

2005
Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15756026

2005
2005
Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15867226

2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15897584

2005
2005
2005
2005
2005
Expression of p63 in diffuse large B-cell lymphoma.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 16082248

2005
2005
2005
2005
2005
2005
2005
A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas.

Diagnostic molecular pathology : the American journal of surgical pathology, part B| PubMed ID: 16319691

2005
[Molecular protocol for HER2/neu analysis in breast carcinoma].

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico| PubMed ID: 16373062

2005
Differential exoprotease activities confer tumor-specific serum peptidome patterns.

The Journal of clinical investigation| PubMed ID: 16395409

2006
Profiling bladder cancer using targeted antibody arrays.

The American journal of pathology| PubMed ID: 16400012

2006
Amplification of CDK4 and MDM2 in malignant melanoma.

Genes, chromosomes & cancer| PubMed ID: 16419059

2006
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 16432078

2006
2006
2006
Autocrine PDGFR signaling promotes mammary cancer metastasis.

The Journal of clinical investigation| PubMed ID: 16741576

2006
2006
2006
2006
2006
2006
2006
2006
2006
2007
Technology insight: will systems pathology replace the pathologist?

Nature clinical practice. Urology| PubMed ID: 17211424

2007
2007
2007
2007
2007
2007
Role of the chromobox protein CBX7 in lymphomagenesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17374722

2007
2007
2007
A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17545525

2007
2007
Improved prediction of prostate cancer recurrence through systems pathology.

The Journal of clinical investigation| PubMed ID: 17557117

2007
2007
Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17671137

2007
2007
2007
Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17921246

2007
2007
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.

The Journal of clinical investigation| PubMed ID: 17948129

2007
2011
2007
2008
A context dependent role for Wnt signaling in tumorigenesis and stem cells.

Cell cycle (Georgetown, Tex.)| PubMed ID: 18239459

2008
TREK-1 is a novel molecular target in prostate cancer.

Cancer research| PubMed ID: 18281496

2008
2008
2008
2008
2008
2008
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 18711180

2008
2008
Molecular alterations associated with bladder cancer initiation and progression.

Scandinavian journal of urology and nephrology. Supplementum| PubMed ID: 18815930

2008
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology| PubMed ID: 18990762

2008
2009
2009
2008
Identification of PMF1 methylation in association with bladder cancer progression.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19088041

2008
2009
2009
2009
2009
2009
2009
2009
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19435838

2009
2009
2009
2009
2009
2010
2009
2009
2009
Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 20008839

2010
miR-19 is a key oncogenic component of mir-17-92.

Genes & development| PubMed ID: 20008935

2009
Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.

International journal of cancer. Journal international du cancer| PubMed ID: 20112337

2010
PHF6 mutations in T-cell acute lymphoblastic leukemia.

Nature genetics| PubMed ID: 20228800

2010
2010
Galectin-3 expression is associated with bladder cancer progression and clinical outcome.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine| PubMed ID: 20401558

2010
2010
2010
2010
2010
2010
2010
2011
2011
2011
2012
2011
Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico| PubMed ID: 21421465

2011
2011
2012
2012
2012
A Role for PML in Innate Immunity.

Genes & cancer| PubMed ID: 21779477

2011
2011
Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool.

Acta cirúrgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia| PubMed ID: 22030824

2011
Personalized approach to prostate cancer prognosis.

Archivos españoles de urología| PubMed ID: 22052759

2011
2012
Mouse models of human bladder cancer as a tool for drug discovery.

Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.]| PubMed ID: 22294368

2010
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico| PubMed ID: 22374423

2012
2012
2012
Translocation renal cell carcinomas in adults: a single-institution experience.

The American journal of surgical pathology| PubMed ID: 22446944

2012
2012
2012
2012
2012
2012
2013
Predicting high-risk disease using tissue biomarkers.

Current opinion in urology| PubMed ID: 23478499

2013
2012
2013
2013
2013
2013
2013
2014
2014
2014
2014
FBXW7 mutations in melanoma and a new therapeutic paradigm.

Journal of the National Cancer Institute| PubMed ID: 24838835

2014
2014
2014
2014
2014
Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.

Expert review of molecular diagnostics| PubMed ID: 25327491

2014
Biomarkers for bladder cancer management: present and future.

American journal of clinical and experimental urology| PubMed ID: 25374904

2014
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2016
Immunopathologic Assessment of PTEN Expression.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 27033068

2016
2016
2016
2016
2016
2016
The role of GATA2 in lethal prostate cancer aggressiveness.

Nature reviews. Urology| PubMed ID: 27872477

2017
2017
2017
2017
2017
2017
2017
2017
2017
2017